Ironwood Pharmaceuticals IRWD Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Ironwood Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The official record: Ironwood Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ironwood Pharmaceuticals's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ironwood Pharmaceuticals's total current liabilities?
- Ironwood Pharmaceuticals (IRWD) reported total current liabilities of $236.31M in Q1 2026.
- How has Ironwood Pharmaceuticals's total current liabilities changed year-over-year?
- Ironwood Pharmaceuticals's total current liabilities increased by 391.3% year-over-year, from $48.1M to $236.31M.
- What is the long-term trend for Ironwood Pharmaceuticals's total current liabilities?
- Over 5 years (2020 to 2025), Ironwood Pharmaceuticals's total current liabilities has grown at a 49.7% compound annual growth rate (CAGR), from $32.17M to $242.22M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.